Clinical Features, Risk Factors, and Management of Candida Keratitis

被引:6
作者
Masoumi, Ahmad [1 ,2 ]
Soleimani, Mohammad [1 ,2 ,3 ]
Azizkhani, Momeneh [1 ,2 ]
Izadi, Alireza [1 ,2 ]
Cheraqpour, Kasra [1 ,2 ]
Tabatabaei, Seyed Ali [1 ,2 ]
Khodaveisi, Sadegh [1 ,2 ]
Aminzadeh, Mehdi [1 ,2 ]
机构
[1] Univ Tehran Med Sci, Ophthalmol Dept, Tehran, Iran
[2] Univ Tehran Med Sci, Farabi Eye Hosp, Eye Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Farabi Eye Hosp, Eye Res Ctr, South Kargar St,Qazvin Sq, Tehran 1336616351, Iran
关键词
Candida keratitis; Candida albicans; fungal keratitis; Non-albicans; risk factor; FUNGAL KERATITIS; EPIDEMIOLOGY; DIAGNOSIS; OUTCOMES; UPDATE;
D O I
10.1080/09273948.2023.2203752
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/AimsTo determine the clinical features, predisposing factors, and management of infectious keratitis caused by Candida spp.MethodsRetrospective chart review.ResultsThe medical records of 52 patients (54 eyes) with Candida keratitis were available for statistical analysis. Thinning of the corneal stroma was identified in 34 eyes (63.0%), and corneal perforation occurred in 16 eyes (29.6%). Corneal thinning and perforation were more common in Candida albicans compared with non-albicans (P-val < .001, P = .09, respectively). The most common predisposing factors for Candida keratitis were topical steroid use (21 patients, 40.4%), previous corneal transplantation (17 patients, 32.7%), and preexisting ocular surface disease (15 patients, 28.8%). Fourteen eyes (25.9%) required cyanoacrylate glue application and 10 eyes (18.5%) underwent therapeutic penetrating keratoplasty (TPK).ConclusionLocal immunosuppression and ocular surface disease play an important role in Candida keratitis. C. albicans appears to be more invasive compared with non-albicans spp.
引用
收藏
页码:1169 / 1174
页数:6
相关论文
共 30 条
  • [1] Report of the Eye Bank Association of America Medical Advisory Board Subcommittee on Fungal Infection After Corneal Transplantation
    Aldave, Anthony J.
    DeMatteo, Jennifer
    Glasser, David B.
    Tu, Elmer Y.
    Iliakis, Bernardino
    Nordlund, Michael L.
    Misko, Jachin
    Verdier, David D.
    Yu, Fei
    [J]. CORNEA, 2013, 32 (02) : 149 - 154
  • [2] Update on the Management of Infectious Keratitis
    Austin, Ariana
    Lietman, Tom
    Rose-Nussbaumer, Jennifer
    [J]. OPHTHALMOLOGY, 2017, 124 (11) : 1678 - 1689
  • [3] Basu Somansu, 2003, Revista Iberoamericana de Micologia, V20, P137
  • [4] Bharathi M. Jayahar, 2003, Indian Journal of Ophthalmology, V51, P315
  • [5] The global incidence and diagnosis of fungal keratitis
    Brown, Lottie
    Leck, Astrid K.
    Gichangi, Michael
    Burton, Matthew J.
    Denning, David W.
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (03) : E49 - E57
  • [6] Fungal keratitis: Mechanisms of infection and management strategies
    Donovan, Christopher
    Arenas, Eduardo
    Ayyala, Ramesh S.
    Margo, Curtis E.
    Espana, Edgar M.
    [J]. SURVEY OF OPHTHALMOLOGY, 2022, 67 (03) : 758 - 769
  • [7] Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model
    Fakhim, Hamed
    Vaezi, Afsane
    Dannaoui, Eric
    Chowdhary, Anuradha
    Nasiry, Davood
    Faeli, Leila
    Meis, Jacques F.
    Badali, Hamid
    [J]. MYCOSES, 2018, 61 (06) : 377 - 382
  • [8] Fungal keratitis in London - Microbiological and clinical evaluation
    Galarreta, David J.
    Tuft, Stephen J.
    Ramsay, Andrew
    Dart, John K. G.
    [J]. CORNEA, 2007, 26 (09) : 1082 - 1086
  • [9] Clinical experience with N-butyl cyanoacrylate tissue adhesive in fungal keratitis
    Garg, P
    Gopinathan, U
    Nutheti, R
    Rao, GN
    [J]. CORNEA, 2003, 22 (05) : 405 - 408
  • [10] Update on fungal keratitis
    Garg, Prashant
    Roy, Aravind
    Roy, Sanhita
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2016, 27 (04) : 333 - 339